39 related articles for article (PubMed ID: 36786990)
1. The impact of SARS-CoV-2 spike mutation on peptide presentation is HLA allomorph-specific.
Ahn YM; Maddumage JC; Grant EJ; Chatzileontiadou DSM; Perera WWJG; Baker BM; Szeto C; Gras S
Curr Res Struct Biol; 2024; 7():100148. PubMed ID: 38742159
[TBL] [Abstract][Full Text] [Related]
2. HLA-II immunopeptidome profiling and deep learning reveal features of antigenicity to inform antigen discovery.
Stražar M; Park J; Abelin JG; Taylor HB; Pedersen TK; Plichta DR; Brown EM; Eraslan B; Hung YM; Ortiz K; Clauser KR; Carr SA; Xavier RJ; Graham DB
Immunity; 2023 Jul; 56(7):1681-1698.e13. PubMed ID: 37301199
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequences.
Wang X; Lu L; Jiang S
Trends Immunol; 2024 Feb; 45(2):81-84. PubMed ID: 38302341
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mimicry and HLA Polymorphisms May Drive Autoimmunity in Recipients of the BNT-162b2 mRNA Vaccine: A Computational Analysis.
Talotta R
Microorganisms; 2023 Jun; 11(7):. PubMed ID: 37512859
[TBL] [Abstract][Full Text] [Related]
5. Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity.
Duette G; Lee E; Martins Costa Gomes G; Tungatt K; Doyle C; Stylianou VV; Lee A; Maddocks S; Taylor J; Khanna R; Bull RA; Martinello M; Sandgren KJ; Cunningham AL; Palmer S
Immunohorizons; 2023 Jun; 7(6):508-527. PubMed ID: 37358499
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
[TBL] [Abstract][Full Text] [Related]
7. Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion.
Hossain A; Akter S; Rashid AA; Khair S; Alam ASMRU
Microb Pathog; 2022 Sep; 170():105699. PubMed ID: 35944840
[TBL] [Abstract][Full Text] [Related]
8. Differences in Presentation of SARS-CoV-2 Omicron Strain Variant BA.1-BA.5 Peptides by HLA Molecules.
Nersisyan SA; Shkurnikov MY; Zhiyanov AP; Novosad VO; Tonevitsky AG
Dokl Biochem Biophys; 2022 Dec; 507(1):298-301. PubMed ID: 36786990
[TBL] [Abstract][Full Text] [Related]
9. A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population.
Kim GJ; Elnaggar JH; Varnado M; Feehan AK; Tauzier D; Rose R; Lamers SL; Sevalia M; Nicholas N; Gravois E; Fort D; Crabtree JS; Miele L
Front Immunol; 2024; 15():1357731. PubMed ID: 38784379
[TBL] [Abstract][Full Text] [Related]
10. T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations.
Nersisyan S; Zhiyanov A; Shkurnikov M; Tonevitsky A
Nucleic Acids Res; 2022 Jan; 50(D1):D883-D887. PubMed ID: 34396391
[TBL] [Abstract][Full Text] [Related]
11. On the peptide binding affinity changes in population-specific HLA repertoires to the SARS-CoV-2 variants Delta and Omicron.
Chen LC; Nersisyan S; Wu CJ; Chang CM; Tonevitsky A; Guo CL; Chang WC
J Autoimmun; 2022 Dec; 133():102952. PubMed ID: 36427410
[TBL] [Abstract][Full Text] [Related]
12. Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice.
Wang Y; Wang B; Zhao Z; Xu J; Zhang Z; Zhang J; Chen Y; Song X; Zheng W; Hou L; Wu S; Chen W
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992472
[TBL] [Abstract][Full Text] [Related]
13. Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules.
Nersisyan S; Zhiyanov A; Zakharova M; Ishina I; Kurbatskaia I; Mamedov A; Galatenko A; Shkurnikov M; Gabibov A; Tonevitsky A
PeerJ; 2022; 10():e13354. PubMed ID: 35502206
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]